Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown originDigestive and Liver Disease, 2021, 53 (7), pp.824-829. ⟨10.1016/j.dld.2021.04.016⟩
Journal articles
hal-03333521v1
|
||
|
Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study.Journal of Clinical Oncology, 2008, 26 (7), pp.1080-5. ⟨10.1200/JCO.2007.12.8223⟩
Journal articles
inserm-00376398v1
|
||
|
Panel gene profiling of small bowel adenocarcinoma, results from the NADEGE prospective cohortInternational Journal of Cancer, 2021, 148 (7), pp.1731-1742. ⟨10.1002/ijc.33392⟩
Journal articles
hal-03038573v1
|